Erythrodermic psoriasis after discontinuation of ixekizumab
Saved in:
Main Authors: | Kathryn Anne Potter, MD (Author), Kiran Motaparthi, MD (Author), Jennifer J. Schoch, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythrodermic psoriasis after COVID-19 vaccination
by: Nicole Trepanowski, BS, et al.
Published: (2022) -
Treatment of erythrodermic psoriasis with apremilast
by: Olivia A. Gioe, MD, et al.
Published: (2021) -
Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
by: Annunziata Raimondo, MD, et al.
Published: (2021) -
Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
by: Song B, et al.
Published: (2024) -
Erythrodermic Psoriasis and Staph-Infective Endocarditis-A Conundrum in Succession
by: Arti Patel MS4, et al.
Published: (2022)